Ufovax ^Company

At Ufovax was invented a nanoparticle vaccine based on one component self-assembling protein nanoparticle (1c-SApNP) platform technology. The vaccine consists of self-assembling virus-like particles made from identical proteins that are synthesized through the insertion of a single plasmid encoding the relevant gene into a CHO or C1 (DYAI) host cell, followed by one-step expression and two subsequent purifications. The vaccine prototype features SARS-CoV-2 protein spikes protruding from a protein nanoparticle scaffold.